In Phoenix , where many residents are managing chronic conditions like diabetes and high blood pressure, GLP-1 medications may offer a dual benefit : managing metabolic health while protecting the brain
However, emerging evidence has revealed the interaction among different types of RCD (226, 227, 234)
Notably, 16.6% (1461 patients) in the semaglutide group stopped because of side effects, compared with just 8.2% (718 patients) in the placebo group
The bottom line Mounjaro and Wegovy are both legitimate UK weight-loss injections, but they are not equal in every respect
Who should avoid semaglutide Semaglutide should not be used by people with: Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Personal or family history of medullary thyroid carcinoma (MTC) Serious allergic reactions to semaglutide Be extra careful if you have pancreatic or kidney problems, diabetic retinopathy, or are pregnant or breastfeeding